[1]宋旭东,罗波,邓学云,等.颅脑损伤术后脑脊液HMGB1、sFas水平与交通性脑积水的关系[J].中国临床神经外科杂志,2022,27(11):909-912916.[doi:10.13798/j.issn.1009-153X.2022.11.009]
 SONG Xu-Dong,LUO Bo,DENG Xue-yun,et al.Relationship between HMGB1 and sFas levels in cerebrospinal fluid and postoperative communicating hydrocephalus of patients with traumatic brain injury[J].,2022,27(11):909-912916.[doi:10.13798/j.issn.1009-153X.2022.11.009]
点击复制

颅脑损伤术后脑脊液HMGB1、sFas水平与交通性脑积水的关系()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
27
期数:
2022年11期
页码:
909-912916
栏目:
论著
出版日期:
2022-11-30

文章信息/Info

Title:
Relationship between HMGB1 and sFas levels in cerebrospinal fluid and postoperative communicating hydrocephalus of patients with traumatic brain injury
文章编号:
1009-153X(2022)11-0909-04
作者:
宋旭东罗波邓学云陈华轩刘毅尚彬
637000 四川,南充市中心医院神经外科(宋旭东、罗波、邓学云、陈华轩、刘毅、尚彬)
Author(s):
SONG Xu-Dong LUO Bo DENG Xue-yun CHEN Hua-xuan LIU Yi SHANG Bin
Department of Neurosurgery, Nanchong Central Hospital, Nanchong 637000, China
关键词:
颅脑损伤交通性脑积水脑脊液高迁移率族蛋白-1可溶性Fas相关性
Keywords:
Traumatic brain injury Cerebrospinal fluid High mobility group box 1 Soluble Fas Communicating hydrocephalus
分类号:
R651.1+5
DOI:
10.13798/j.issn.1009-153X.2022.11.009
文献标志码:
A
摘要:
目的 探讨颅脑损伤(TBI)术后脑脊液HMGB1、sFas水平变化及其与交通性脑积水的关系。方法 2017年1月至2021年3月前瞻性收集符合标准的TBI共237例(观察组),取同期仅有头皮裂伤且无感染40例作为对照,应用酶联免疫吸附法检测脑脊液HMGB1、sFas水平。观察组术后3个月内采用临床表现联合影像学表现诊断交通性脑积水。结果 术后1 d,观察组脑脊液HMGB1水平[(17.47±5.74)pg/ml]明显高于对照组[(8.89±4.06)pg/ml;P<0.05],脑脊液sFas水平[(96.71±30.29)pg/ml]明显高于对照组[(22.78±11.63)pg/ml;P<0.05]。术后3个月内,观察组发生交通性脑积水43例(脑积水组),无交通性脑积水194例(无脑积水组)。与无脑积水组相比,脑积水组术后3、7、14 d脑脊液HMGB1水平明显增高(P<0.05),术后1、3、7、14 d脑脊液sFas水平明显增高(P<0.05)。多因素logistic回归分析显示,术后3、7、14 d脑脊液HMGB1和sFas水平增高是TBI术后发生交通性脑积水的独立预测因素(P<0.05)。ROC曲线分析显示,术后3、7、14 d脑脊液HMGB1、sFas水平增高对TBI术后发生交通性脑积水均具有一定的预测价值(P<0.05),术后7 d脑脊液HMGB1、sFas水平同时增高预测效果最佳(P<0.05)。结论 脑脊液HMGB1、sFas水平与TBI术后发生交通性脑积水有关,术后7 d两者同时增高对预测发生交通性脑积水具有良好的价值。
Abstract:
Objective To investigate the relationship between the levels of high mobility group box 1 (HMGB1) and soluble Fas (sFas) in cerebrospinal fluid (CSF) and postoperative communicating hydrocephalus of patients with traumatic brain injury (TBI). Methods A total of 237 patients with TBI (observation group) were prospectively collected from January 2017 to March 2021, and 40 patients with scalp trauma without infection were selected as control group. The levels of CSF HMGB1 and sFas were detected by ELISA. The postoperative communicating hydrocephalus in observation group was diagnosed by clinical manifestations combined with imaging manifestations within 3 months after operation. Results One day after operation, the CSF HMGB1 level in the observation group [(17.47±5.74) pg/ml] was significantly higher than that [(8.89±4.06) pg/ml] in the control group (P<0.05), the CSF sFas level [(96.71±30.29) pg/ml] was also significantly higher than that [(22.78±11.63) pg/ml] in the control group (P<0.05). Within 3 months after surgery, 43 TBI patients were diagnosed as communicating hydrocephalus (hydrocephalus group) and 194 were not (non-hydrocephalus group). Compared with the non-hydrocephalus group, the CSF HMGB1 levels in the hydrocephalus group were significantly increased 3, 7 and 14 days after operation (P<0.05), and the CSF sFas levels were significantly increased 1, 3, 7 and 14 days after operation (P<0.05). Multivariate logistic regression analysis showed that the increase of CSF HMGB1 and sFas level 3, 7 and 14 days after surgery were independent predictors of communicating hydrocephalus (P<0.05). ROC curve analysis showed that the increase of CSF HMGB1 and sFas levels 3, 7 and 14 days after surgery had certain predictive value for the occurrence of communicating hydrocephalus (P<0.05), and the increase of CSF HMGB1 and sFas levels 7 days after surgery had the best predictive value (P<0.05). Conclusions CSF HMGB1 and sFas levels are related to the occurrence of communicating hydrocephalus of TBI patients after surgery, and the increase of CSF levels of HMGB1 and sFas 7 days after surgery has a good value in predicting the occurrence of communicating hydrocephalus.

参考文献/References:

[1] Brazinova A, Rehorcikova V, Taylor MS, et al. Epidemiology of traumatic brain injury in Europe: a living systematic review [J]. J Neurotrauma, 2021, 38(10): 1411-1440.
[2] Hutchinson PJ, Kolias AG, Tajsic T, et al. Consensus statement from the International Consensus Meeting on the Role of Decompressive Craniectomy in the Management of Traumatic Brain Injury : consensus statement [J]. Acta Neurochir (Wien), 2019, 161(7): 1261-1274.
[3] Kim JH, Ahn JH, Oh JK, et al. Factors associated with the development and outcome of hydrocephalus after decom-pressive craniectomy for traumatic brain injury [J]. Neuro-surg Rev, 2021, 44(1): 471-478.
[4] 中华医学会创伤学分会颅脑创伤专业委员会. 颅脑创伤病人脑脊液管理中国专家共识[J]. 中华神经外科杂志,2019,35(8):760-764.
[5] 中国医师协会神经外科医师分会,中国神经创伤专家委员会. 中国颅脑创伤外科手术指南[J]. 中华神经创伤外科电子杂志,2015,1(1):59-60.
[6] Chen KH, Lee CP, Yang YH, et al. Incidence of hydrocephalus in traumatic brain injury: a nationwide population-based cohort study [J]. Medicine (Baltimore), 2019, 98(42): e17568.
[7] Chen S, Luo J, Reis C, et al. Hydrocephalus after subarachnoid hemorrhage: pathophysiology, diagnosis, and treatment [J]. Biomed Res Int, 2017, 2017: 8584753.
[8] 刘 彤,何沛邦,李明昌. 特发性正常压力脑积水发病机制的研究新进展[J]. 中国临床神经外科杂志,2021,26(2):133-136.
[9] Yang H, Wang H, Andersson U. Targeting inflammation driven by HMGB1 [J]. Front Immunol, 2020, 11: 484.
[10] Volchuk A, Ye A, Chi L, et al. Indirect regulation of HMGB1release by gasdermin D [J]. Nat Commun, 2020, 11(1): 4561.
[11] Paudel YN, Angelopoulou E, Piperi C, et al. HMGB1-mediated neuroinflammatory responses in brain injuries: potential mechanisms and therapeutic opportunities [J]. Int J Mol Sci, 2020, 21(13): 4609.
[12] Muhammad S, Chaudhry SR, Kahlert UD, et al. Targeting high mobility group box 1 in subarachnoid hemorrhage: a systematic review [J]. Int J Mol Sci, 2020, 21(8): 2709.
[13] Watanabe M, Miyajima M, Nakajima M, et al. Expression analysis of high mobility group box-1 protein (HMGB-1) in the cerebral cortex,hippocampus,and cerebellum of the congenital hydrocephalus (H-Tx) rat [J]. Acta Neurochir Suppl, 2012, 113: 91-96.
[14] Lorente L, Martín MM, Ortiz-López R, et al. Association between serum sFasL concentrations and sepsis mortality [J]. Infect Dis (Lond), 2021, 53(1): 38-43.
[15] Kajikawa O, Herrero R, Chow YH, et al. The bioactivity of soluble Fas ligand is modulated by key amino acids of its stalk region [J]. PLoS One, 2021, 16(6): e0253260.
[16] Lorente L, Martín MM, Pérez-Cejas A, et al. High serum soluble Fas ligand levels in non-survivor traumatic brain injury patients [J]. Neurocrit Care, 2021, 35(1): 249-254.
[17] Felderhoff-Mueser U, Herold R, Hochhaus F, et al. Increased cerebrospinal fluid concentrations of soluble Fas (CD95/Apo-1) in hydrocephalus [J]. Arch Dis Child, 2001, 84(4): 369-372.
[18] Zhong H, Li X, Zhou S, et al. Interplay between RAGE and TLR4 regulates HMGB1-induced inflammation by promoting cell surface expression of RAGE and TLR4 [J]. J Immunol, 2020, 205(3): 767-775.
[19] Felderhoff-Mueser U, Buhrer C, Groneck P, et al. Soluble Fas (CD95/Apo-1),soluble Fas ligand,and activated caspase 3 in the cerebrospinal fluid of infants with posthemorrhagic and nonhemorrhagic hydrocephalus [J]. Pediatr Res, 2003, 54(5): 659-664.

相似文献/References:

[1]张善纲 综述.现代战争中颅脑损伤的特点及功能康复[J].中国临床神经外科杂志,2015,(11):701.[doi:10.13798/j.issn.1009-153X.2015.11.021]
[2]钟秀均 黄书岚.复方醒脑液治疗颅脑损伤后综合征的临床观察[J].中国临床神经外科杂志,2016,(05):278.[doi:10.13798/j.issn.1009-153X.2016.05.007]
 ZHONG Xiu-jun,HUANG Shu-lan..Clinical observation on treatment of compound decoction for cerebral prorection for post-traumatic brain syndrome[J].,2016,(11):278.[doi:10.13798/j.issn.1009-153X.2016.05.007]
[3]李国亮 邸 方 杨亚东.香芹酚通过抑制脑水肿与氧化应激反应保护大鼠 颅脑损伤[J].中国临床神经外科杂志,2016,(05):283.[doi:10.13798/j.issn.1009-153X.2016.05.009]
 LI Guo-liang,DI Fang,YANG Ya-dong..Carvacrol protects against traumatic brain injury in rats through suppressing the brain edma and oxidative stress[J].,2016,(11):283.[doi:10.13798/j.issn.1009-153X.2016.05.009]
[4]罗心凯 陈治标 陈谦学.免缝胶原海绵人工硬脑膜在颅脑损伤大骨瓣减压术中的应用[J].中国临床神经外科杂志,2016,(06):357.[doi:10.13798/j.issn.1009-153X.2016.06.012]
 LUO Xin-kai,CHEN Zhi-biao,CHEN Qian-xue..Application of collagen sponge artificial dura without suturing to big bone flap decompression after traumatic brain injury[J].,2016,(11):357.[doi:10.13798/j.issn.1009-153X.2016.06.012]
[5]贺瑛福 肖宗宇 马进海 许常林 裴 杰 袁 岗 张广华  巨 虎.高海拔地区重型颅脑损伤血清FSH、LH、PRL的变化[J].中国临床神经外科杂志,2016,(06):359.[doi:10.13798/j.issn.1009-153X.2016.06.013]
 HE Ying-fu,XIAO Zong-yu,MA Jin-hai,et al.Changes in serum FSH, LH and PRL levels in the patients with severe traumatic brain injury in plateau[J].,2016,(11):359.[doi:10.13798/j.issn.1009-153X.2016.06.013]
[6]满明昊 李立宏 杨彦龙 李 敏 郭少春.颅脑损伤术后细胞免疫指标变化及脾多肽对其影响[J].中国临床神经外科杂志,2016,(06):362.[doi:10.13798/j.issn.1009-153X.2016.06.014]
 MAN Ming-hao,LI Li-hong,YANG Yan-yong,et al.Changes in peripheral cells immunity after operation and effect of spleen polypeptide on them in patients with traumatic brain injury[J].,2016,(11):362.[doi:10.13798/j.issn.1009-153X.2016.06.014]
[7]程 勇 秦加新 戢翰升 李 刚 聂劲林 李 强.颅脑损伤术中急性脑膨出的相关因素分析[J].中国临床神经外科杂志,2016,(06):374.[doi:10.13798/j.issn.1009-153X.2016.06.019]
[8]张一帆 综述 张国来 审校.弥漫性轴索损伤影像学诊断的研究进展[J].中国临床神经外科杂志,2016,(07):442.[doi:10.13798/j.issn.1009-153X.2016.07.020]
[9]陈吉钢 张丹枫 魏嘉良 邹 伟 侯立军.创伤性眶上裂综合征的治疗陈吉钢[J].中国临床神经外科杂志,2016,(04):200.[doi:10.13798/j.issn.1009-153X.2016.04.003]
 CHEN Ji-gang,ZHANG Dan-feng,WEI Jiang-liang,et al.Management of traumatic superior orbital fissure syndrome (report of 22 cases)[J].,2016,(11):200.[doi:10.13798/j.issn.1009-153X.2016.04.003]
[10]肖连福 黄瑞宏 陈昌勇.外伤性颅内静脉窦血栓形成1例[J].中国临床神经外科杂志,2016,(04):256.[doi:10.13798/j.issn.1009-153X.2016.04.024]

备注/Memo

备注/Memo:
(2021-10-15收稿,2022-08-30修回)
更新日期/Last Update: 2022-12-31